Leggett Thomas sold STOK
March 18, 2026 · Form 4 insider transaction
Leggett Thomas sold 172 shares of Stoke Therapeutics, Inc. at $31.79 per share, a transaction worth $5.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
172
Price
$31.79
Total value
$5.5K
InsiderLeggett Thomas
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 18, 2026
Filing dateMarch 19, 2026
Shares owned after10,209
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.46 per share, inclusive.